492 related articles for article (PubMed ID: 28232483)
1. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
[TBL] [Abstract][Full Text] [Related]
2. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
[TBL] [Abstract][Full Text] [Related]
3. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Van Meenen D; Doege A; Alefeld E; Haase A; Beier M; Kiefer T; Biewald E; Metz K; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293469
[TBL] [Abstract][Full Text] [Related]
4. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
[TBL] [Abstract][Full Text] [Related]
5. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
6. The collectrin-like part of the SARS-CoV-1 and -2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17.
Niehues RV; Wozniak J; Wiersch F; Lilienthal E; Tacken N; Schumertl T; Garbers C; Ludwig A; Düsterhöft S
FASEB J; 2022 Mar; 36(3):e22234. PubMed ID: 35199397
[TBL] [Abstract][Full Text] [Related]
7. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17.
Alabi RO; Lora J; Celen AB; Maretzky T; Blobel CP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673337
[TBL] [Abstract][Full Text] [Related]
9. Expression of ADAM17 and ADAM10 in nasal polyps.
Bae WY; Park SK; Kim do H; Koh TK; Hur DY; Chueh HW
Int Forum Allergy Rhinol; 2016 Jul; 6(7):731-6. PubMed ID: 27012683
[TBL] [Abstract][Full Text] [Related]
10. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.
Park GB; Kim D
Mol Cell Biochem; 2017 Jan; 425(1-2):191-202. PubMed ID: 27837433
[TBL] [Abstract][Full Text] [Related]
11. A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development.
Toonen JA; Ronchetti A; Sidjanin DJ
PLoS One; 2016; 11(5):e0156184. PubMed ID: 27224017
[TBL] [Abstract][Full Text] [Related]
12. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
Camodeca C; Nuti E; Tosetti F; Poggi A; D'Arrigo C; Zocchi MR; Rossello A
ChemMedChem; 2018 Oct; 13(19):2119-2131. PubMed ID: 30102846
[TBL] [Abstract][Full Text] [Related]
14. The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.
Speck N; Brandsch C; Schmidt N; Yazdekhasti N; Hirche F; Lucius R; Rimbach G; Stangl GI; Reiss K
J Nutr; 2015 Jun; 145(6):1218-26. PubMed ID: 25926412
[TBL] [Abstract][Full Text] [Related]
15. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
16. Stimulated release and functional activity of surface expressed metalloproteinase ADAM17 in exosomes.
Groth E; Pruessmeyer J; Babendreyer A; Schumacher J; Pasqualon T; Dreymueller D; Higashiyama S; Lorenzen I; Grötzinger J; Cataldo D; Ludwig A
Biochim Biophys Acta; 2016 Nov; 1863(11):2795-2808. PubMed ID: 27599715
[TBL] [Abstract][Full Text] [Related]
17. Mechanical activation of lung epithelial cells through the ion channel Piezo1 activates the metalloproteinases ADAM10 and ADAM17 and promotes growth factor and adhesion molecule release.
Grannemann C; Pabst A; Honert A; Schieren J; Martin C; Hank S; Böll S; Bläsius K; Düsterhöft S; Jahr H; Merkel R; Leube R; Babendreyer A; Ludwig A
Biomater Adv; 2023 Sep; 152():213516. PubMed ID: 37348330
[TBL] [Abstract][Full Text] [Related]
18. The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17.
Zheng Y; Verhoeff TA; Perez Pardo P; Garssen J; Kraneveld AD
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374371
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.
Park GB; Kim D
Mol Cell Biochem; 2018 Feb; 439(1-2):199-211. PubMed ID: 28819788
[TBL] [Abstract][Full Text] [Related]
20. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
